Baker Bros. Advisors LP Iveric Bio, Inc. Transaction History

Baker Bros. Advisors LP

  • $7.9 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$7.07 - $17.5 $9.94 Million - $24.6 Million
-1,406,037 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$4.01 - $6.29 $920,150 - $1.44 Million
-229,464 Reduced 14.03%
1,406,037 $7.93 Million
Q1 2020

May 15, 2020
BUY
$2.83 - $8.44 $4.23 Million - $12.6 Million
1,493,751 Added 1053.79%
1,635,501 $5.63 Million
Q4 2019

Feb 14, 2020
BUY
$0.93 - $8.58 $131,827 - $1.22 Million
141,750 New
141,750 $1.22 Million

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Baker Bros. Advisors LP Portfolio

Follow Baker Bros. Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Bros. Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email